Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited
Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited is a federal patent - anda lawsuit filed on 06/28/2019 in the District Court, D. New Jersey. The case was terminated on 01/06/2020.
- Court
- District Court, D. New Jersey (D.N.J.)
Official Court Website → - Assigned judge
- Freda L. Wolfson · 5,250 cases in index
- Docket number
- 3:19-cv-14502
- Cause
- 35:271 Patent Infringement
35 U.S.C. § 271 — Patent infringement - Nature of suit
- 835 Patent - Abbreviated New Drug Application(ANDA)
Hatch-Waxman patent disputes over a generic-drug (ANDA) application. - Jurisdiction
- Federal Question
- Jury demand
- None
- Date filed
- 06/28/2019
- Date terminated
- 01/06/2020
623 Patent - ANDA cases in this court are indexed here.
Parties
- plaintiff · Bausch Health Ireland Limited Pharmaceuticals & Biotechnology · 51 cases
- defendant · Glenmark Pharmaceuticals Limited · 12 cases
Part of a Larger Litigation Pattern
This is one of 13 Patent - ANDA cases in our index naming Glenmark Pharmaceuticals Limited — a possible mass-tort or coordinated-litigation cluster.
About Patent - ANDA Lawsuits
ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
Frequently Asked Questions
What is Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited?
Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited is a federal patent - anda lawsuit filed on 06/28/2019 in the District Court, D. New Jersey. The case was terminated on 01/06/2020. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What type of case is this?
It is classified as “Patent - ANDA” under the federal nature-of-suit system. ANDA patent cases arise when a generic-drug maker files an Abbreviated New Drug Application and the brand-name patent holder sues for infringement under the Hatch-Waxman Act.
What court is the case in?
The case is in the District Court, D. New Jersey, docket number 3:19-cv-14502.
When was the case filed?
Bausch Health Ireland Limited v. Glenmark Pharmaceuticals Limited was filed on 06/28/2019. It was terminated on 01/06/2020.
What law is the case brought under?
The docket lists the cause as 35 U.S.C. § 271 — Patent infringement.
Other Cases Involving These Parties
Related Patent - ANDA Cases
Source: public U.S. federal court record (docket 15860209).